AI-generated summary
This protocol describes a planned randomized, placebo-controlled trial comparing photobiomodulation and ischemic preconditioning, applied before eccentric exercise, for protection against exercise-induced muscle damage. The authors plan to enroll healthy men aged 18 to 35 years, with about 15 per group, and to assess maximal voluntary isometric contraction and other markers. No results are reported, as this is a study protocol.
- Participants
- 45
- Who or what was studied
- Healthy men aged 18 to 35 years (planned)
- Limits stated in the abstract
- This is a protocol with no results reported, and the abstract does not state the wavelengths or doses of the planned interventions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Exercise-induced muscle damage (EIMD) occurs after unaccustomed eccentric exercise and may impair muscle recovery. Preconditioning with photobiomodulation (PBM) or ischemic preconditioning (IPC) may mitigate EIMD; however, no study has directly compared their effectiveness. This study aims to compare the effects of PBM and IPC applied prior to eccentric exercise on indirect markers of EIMD and associated perceptual responses. We hypothesized that MVIC trajectories would differ among the PBM, IPC, and sham groups, with PBM expected to provide greater preservation of MVIC than IPC. A prospective, randomized, placebo-controlled clinical trial with concealed allocation, blinded outcome assessors and statistician, and intention-to-treat analysis will be conducted. Healthy men (18-35 years) will be randomly allocated to PBM, IPC, or sham groups (n = 15 per group). After the intervention, participants will perform an eccentric exercise protocol for the elbow flexors consisting of 30 repetitions using a dumbbell load numerically matched to maximal voluntary isometric contraction (MVIC) values, with 45-second rest intervals. The primary outcome will be MVIC. Secondary outcomes include rate of force development, delayed-onset muscle soreness, pressure pain threshold, ultrasound echo intensity, range of motion, perceived exertion, and affective responses. Outcomes will be assessed at baseline, immediately after exercise (only MVIC), and at 24-, 48-, and 72-hours post-exercise. The primary analysis will assess the group × time interaction on MVIC using linear mixed-effects models, while secondary outcomes will be analyzed exploratorily. This study will provide, to our knowledge, the first direct comparison between PBM and IPC as preconditioning strategies to attenuate EIMD. The findings may help determine the most effective and clinically applicable intervention by considering both physiological and perceptual responses, thereby supporting decision-making in clinical and sports settings. Trial registrationBrazilian Registry of Clinical Trials (REBEC), RBR-6gr5kf; registered February 19, 2020; amended August 26, 2026.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Sham, Intention-to-treat analysis, Placebo-controlled, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.